Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4033)
All Articles published online
|
Apr 7, 2010 (publication date) through Dec 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Thanasai J, Limpaiboon T, Jearanaikoon P, Sripa B, Pairojkul C, Tantimavanich S, Miwa M. Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma. World J Gastroenterol 2010; 16(13): 1631-1638 [PMID: 20355241 DOI: 10.3748/wjg.v16.i13.1631] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i13/1631.htm |
| Number | Citing Articles |
| 1 |
Shinichi Aishima. Diversity of tumor vessels in intrahepatic cholangiocarcinoma. Kanzo 2015; 56(8): 406 doi: 10.2957/kanzo.56.406
|
| 2 |
Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 2022; 14(10): 2563 doi: 10.3390/cancers14102563
|
| 3 |
Nobuya Kobashi, Hiroki Matsumoto, Songji Zhao, Shunsuke Meike, Yuki Okumura, Tsutomu Abe, Hiromichi Akizawa, Kazue Ohkura, Ken-ichi Nishijima, Nagara Tamaki, Yuji Kuge. The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine. Journal of Nuclear Medicine 2016; 57(8): 1276 doi: 10.2967/jnumed.115.165811
|
| 4 |
NICHAPAVEE NUTTHASIRIKUL, CHARIYA HAHNVAJANAWONG, ANCHALEE TECHASEN, TEMDUANG LIMPAIBOON, CHANVIT LEELAYUWAT, SIRI CHAU-IN, PATCHAREE JEARANAIKOON. Targeting the Δ133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells. International Journal of Oncology 2015; 47(6): 2153 doi: 10.3892/ijo.2015.3188
|
| 5 |
Shuangling Li, Hongli Yang, Kun Li, Guiling Fan, Li Deng, Changqing Xu. Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma. Cell Biochemistry and Function 2020; 38(6): 743 doi: 10.1002/cbf.3541
|
| 6 |
Johannes Byrling, Theresa Kristl, Dingyuan Hu, Indira Pla, Aniel Sanchez, Agata Sasor, Roland Andersson, György Marko-Varga, Bodil Andersson. Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02498-3
|
| 7 |
E Di Gennaro, G Piro, M I Chianese, R Franco, A Di Cintio, T Moccia, A Luciano, I de Ruggiero, F Bruzzese, A Avallone, C Arra, A Budillon. Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase. British Journal of Cancer 2010; 103(11): 1680 doi: 10.1038/sj.bjc.6605969
|
| 8 |
Annett Maderer, Frederic Fiteni, Erik Tanis, Murielle Mauer, Thomas Schmitt, Daniela E. Aust, Manfred P. Lutz, Felicitas Roelofson, Christiane Gog, Arndt Weinmann, Claus H. Koehne, Markus Moehler, Thomas Thomaidis. CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset. Acta Oncologica 2021; 60(11): 1543 doi: 10.1080/0284186X.2021.1959057
|
| 9 |
Kyun Woo Park, Eun-Seon Jung, Dong-Gu Kim, Young-Kyung Yoo, Tae-Ho Hong, In Seok Lee, Yoon Ho Koh, Ji-Hoon Kim, Myung Ah Lee. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. Cancer Research and Treatment 2013; 45(1): 63 doi: 10.4143/crt.2013.45.1.63
|
| 10 |
WAREEPORN WATTANAWONGDON, CHARIYA HAHNVAJANAWONG, NISANA NAMWAT, SIRIMAS KANCHANAWAT, THIDARUT BOONMARS, PATCHAREE JEARANAIKOON, CHANWIT LEELAYUWAT, ANCHALEE TECHASEN, WUNCHANA SEUBWAI. Establishment and characterization of gemcitabine-resistant human cholangiocarcinoma cell lines with multidrug resistance and enhanced invasiveness. International Journal of Oncology 2015; 47(1): 398 doi: 10.3892/ijo.2015.3019
|
| 11 |
Wing-Kee Lee, Michelle Maaß, Amy Quach, Nataliya Poscic, Holly Prangley, Erin-Claire Pallott, Jiyoon L. Kim, Jason S. Pierce, Besim Ogretmen, Anthony H. Futerman, Frank Thévenod. Dependence of ABCB1 transporter expression and function on distinct sphingolipids generated by ceramide synthases-2 and -6 in chemoresistant renal cancer. Journal of Biological Chemistry 2022; 298(2): 101492 doi: 10.1016/j.jbc.2021.101492
|
| 12 |
Shuichi Mitsunaga, Masafumi Ikeda, Shogo Nomura, Chigusa Morizane, Akiko Todaka, Naoto Yamamoto, Ken Kamata, Hiroo Yanagibashi, Nobumasa Mizuno, Yasuyuki Kawamoto, Kunihito Gotoh, Hirofumi Shirakawa, Naohiro Okano, Tatsuya Nomura, Kazunari Tanaka, Amane Takahashi, Shintaro Yagi, Koji Ohta, Yukiko Takayama, Haruo Miwa, Hiroaki Nagano, Yasushi Kojima, Terumasa Hisano, Munenori Tahara, Yasunaru Sakuma, Hiroyuki Arai, Ikuo Nakamura, Hiroshi Katayama, Masaru Konishi, Makoto Ueno. 5‐Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S‐1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1). Journal of Hepato-Biliary-Pancreatic Sciences 2024; 31(12): 886 doi: 10.1002/jhbp.12071
|